Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease

British Journal of Pharmacology

Volumn 173, Issue 12, 2016, Pages 2016-2029

  Patel, K P ^a   Giraud, A S ^b   Samuel, C S ^a   Royce, S G ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FIBRONECTIN; GELATINASE A; GELATINASE B; RESPIRATORY TRACT AGENT; SERELAXIN; TRANSFORMING GROWTH FACTOR BETA1; TREFOIL FACTOR 2; UNCLASSIFIED DRUG; TFF2 PROTEIN, MOUSE;

AIRWAY REMODELING; ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; LUNG COMPLIANCE; LUNG FIBROSIS; LUNG PARENCHYMA; MOUSE; MYOFIBROBLAST; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; COMBINATION DRUG THERAPY; COMPLICATION; DRUG EFFECTS; FIBROSIS; HYPERSENSITIVITY;

ANIMALS; ASTHMA; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; HYPERSENSITIVITY; MICE; MICE, INBRED BALB C; TREFOIL FACTOR-2;

EID: 84965114034     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13494     Document Type: Article

References (50)

1. Alexander SPH, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol 172: 5956-5978.
2. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015a). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744-5869.
3. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024-6109.
4. Aamann L, Vestergaard EM, Gronbaek H, (2014). Trefoil factors in inflammatory bowel disease. World J Gastroent 20: 3223-3230.
5. Baccari MC, Bani D, Bigazzi M, Calamai F, (2004). Influence of relaxin on the neurally induced relaxant responses of the mouse gastric fundus. Biol Reprod 71: 1325-1329.
6. Bani D, (1997). Relaxin: a pleiotropic hormone. Gen Pharmacol 28: 13-22.
7. Bani D, Ballati L, Masini E, Bigazzi M, Sacchi TB, (1997). Relaxin counteracts asthma-like reaction induced by inhaled antigen in sensitized guinea pigs. Endocrinology 138: 1909-1915.
8. Bennett RG, (2009). Relaxin and its role in the development and treatment of fibrosis. Transl Res 154: 1-6.
9. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA, et al., (2015). Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 172: 3461-3471.
10. Dahl R, (2006). Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 100: 1307-1317.
11. de Boer WI, Sharma HS, Baelemans SM, Hoogsteden HC, Lambrecht BN, Braunstahl GJ, (2008). Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol 86: 105-112.
12. Dschietzig T, Bartsch C, Stangl V, Baumann G, Stangl K, (2004). Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist. FASEB J 18: 1536-1538.
13. Dschietzig T, Brecht A, Bartsch C, Baumann G, Stangl K, Alexiou K, (2012). Relaxin improves TNF-alpha-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling. Cardiovasc Res 95: 97-107.
14. Elias JA, Zhu Z, Chupp G, Homer RJ, (1999). Airway remodelling in asthma. J Clin Invest 104: 1001-1006.
15. Fleming L, Wilson N, Bush A, (2007). Difficult to control asthma in children. Curr Opin Allergy Clin Immunol 7: 190-195.
16. Gallop PM, Paz MA, (1975). Posttranslational protein modifications, with special attention to collagen and elastin. Physiol Revs 55: 418-487.
17. Girodet PO, Ozier A, Bara I, Tunon de Lara JM, Marthan R, Berger P, (2011). Airway remodelling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol Therapeut 130: 325-337.
18. Gurusamy M, Nasseri S, Lee H, Jung B, Lee D, Khang G, et al., (2016). Kinin B1 receptor antagonist BI113823 reduces allergen-induced airway inflammation and mucus secretion in mice. Pharm Res 104: 132-139.
19. Hetherington KJ, Heaney LG, (2015). Drug therapies in severe asthma-the era of stratified medicine. Clin Med (Lond) 15: 452-456.
20. Hoffmann W, (2007). TFF (trefoil factor family) peptides and their potential roles for differentiation processes during airway remodelling. Curr Med Chem 14: 2716-2719.
21. Holgate ST, (2000). Epithelial damage and response. Clin Exp Allergy 30 (Suppl 1): 37-41.
22. Holgate ST, (2008a). The airway epithelium is central to the pathogenesis of asthma. Allergol Int 57: 1-10.
23. Holgate ST, (2008b). Pathogenesis of asthma. Clin Exp Allergy 38: 872-897.
24. Holgate ST, Davies DE, Puddicombe S, Richter A, Lackie P, Lordan J, et al., (2003). Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur Respir J Suppl 44: 24s-29s.
25. Huang X, Gai Y, Yang N, Lu B, Samuel CS, Thannickal VJ, et al., (2011). Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am J Pathol 179: 2751-2765.
26. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
27. Knight DA, Holgate ST, (2003). The airway epithelium: structural and functional properties in health and disease. Respirology 8: 432-446.
28. Kumar RK, Herbert C, Foster PS, (2008). The "classical" ovalbumin challenge model of asthma in mice. Curr Drug Targets 9: 485-494.
29. Liao TD, Yang XP, D'Ambrosio M, Zhang Y, Rhaleb NE, Carretero OA, (2010). N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research. Hypertension 55: 459-467.
30. Masini E, Cuzzocrea S, Mazzon E, Muia C, Vannacci A, Fabrizi F, et al., (2006). Protective effects of relaxin in ischemia/reperfusion-induced intestinal injury due to splanchnic artery occlusion. Br J Pharmacol 148: 1124-1132.
31. McGrath JC, Lilley E, (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189-3193.
32. Moore XL, Tan SL, Lo CY, Fang L, Su YD, Gao XM, et al., (2007). Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes. Endocrinology 148: 1582-1589.
33. Mu X, Urso ML, Murray K, Fu F, Li Y, (2010). Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice. Am J Pathol 177: 2399-2410.
34. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al., (2014). The IUPHAR/BPS guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucleic Acids Res 42: D1098-D1106.
35. Qu W, Huang H, Li K, Qin C, (2014). Danshensu-mediated protective effect against hepatic fibrosis induced by carbon tetrachloride in rats. Pathol Biol 62: 348-353.
36. Royce SG, Li X, Tortorella S, Goodings L, Chow BS, Giraud AS, et al., (2014a). Mechanistic insights into the contribution of epithelial damage to airway remodelling. Novel therapeutic targets for asthma. Am J Respir Cell Mol Biol 50: 180-192.
37. Royce SG, Lim C, Muljadi RC, Samuel CS, Ververis K, Karagiannis TC, et al., (2013a). Trefoil factor-2 reverses airway remodelling changes in allergic airways disease. Am J Respir Cell Mol Biol 48: 135-144.
38. Royce SG, Lim CX, Patel KP, Wang B, Samuel CS, Tang ML, (2014b). Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease. Clin Exp Allergy 44: 1399-1408.
39. Royce SG, Miao YR, Lee M, Samuel CS, Tregear GW, Tang ML, (2009). Relaxin reverses airway remodelling and airway dysfunction in allergic airways disease. Endocrinology 150: 2692-2699.
40. Royce SG, Moodley Y, Samuel CS, (2014c). Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis. Pharm Therap 141: 250-260.
41. Royce SG, Patel KP, Samuel CS, (2014d). Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma. Lab Invest 94: 1326-1339.
42. Royce SG, Sedjahtera A, Samuel CS, Tang ML, (2013b). Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease. Clin Sci (Lond) 124: 41-51.
43. Royce SG, Shen M, Patel KP, Huuskes BM, Ricardo SD, Samuel CS, (2015). Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease. Stem Cell Res 15: 495-505.
44. Tang ML, Wilson JW, Stewart AG, Royce SG, (2006). Airway remodelling in asthma: current understanding and implications for future therapies. Pharm Therap 112: 474-488.
45. Trautmann A, Kruger K, Akdis M, Muller-Wening D, Akkaya A, Brocker EB, et al., (2005). Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol 138: 142-150.
46. Unemori EN, Lewis M, Constant J, Arnold G, Grove BH, Normand J, et al., (2000). Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Rep Regen 8: 361-370.
47. Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson ME, et al., (1996). Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 98: 2739-2745.
48. Woessner JF Jr, (1995). Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 248: 510-528.
49. Xu ZP, Huo JM, Sang YL, Kang J, Li X, (2012). Effects of arsenic trioxide (As(2)O(3)) on airway remodeling in a murine model of bronchial asthma. Canad J Physiol Pharmacol 90: 1576-1584.
50. Zhang Y, Moffatt MF, Cookson WO, (2012). Genetic and genomic approaches to asthma: new insights for the origins. Curr Opin Pulm Med 18: 6-13.